PHVS included in ETFs
Dates are bounded by retained official portfolio snapshots; baseline presence is never presented as an original addition date.
Current ETFs holding PHVS
11 latest ETF portfolios currently report this security. This page shows rows 1–11 of 11.
| ETF | Fund | Weight | Added / first observed | Latest report |
|---|---|---|---|---|
| SBIO | ALPS Medical Breakthroughs ETF | 1.174321% | 2026-02-28 | 2026-02-28 |
| BBC | Virtus Biotech Clinical Trials Etf | 0.948877% | 2024-07-31 | 2026-04-30 |
| EWN | iShares MSCI Netherlands ETF | 0.211899% | 2026-02-28 | 2026-02-28 |
| IBBQ | Invesco Nasdaq Biotechnology ETF | 0.134599% | 2026-02-28 | 2026-02-28 |
| BIB | ProShares Ultra Nasdaq Biotechnology | 0.091569% | 2026-02-28 | 2026-02-28 |
| GWX | State Street(R) SPDR(R) S&P(R) International Small Cap ETF | 0.08172% | 2026-03-31 | 2026-03-31 |
| IBB | iShares Biotechnology ETF | 0.066763% | 2026-03-31 | 2026-03-31 |
| IEUS | iShares MSCI Europe Small-Cap ETF | 0.042503% | 2026-04-30 | 2026-04-30 |
| SCZ | iShares MSCI EAFE Small-Cap ETF | 0.018966% | 2026-04-30 | 2026-04-30 |
| DBEZ | Xtrackers MSCI Eurozone Hedged Equity ETF | 0.006766% | 2024-11-29 | 2026-02-27 |
| IEFA | iShares Core MSCI EAFE ETF | 0.001924% | 2026-04-30 | 2026-04-30 |